FEI Tribunal Publishes Final Decision in Endurance Prohibited Substance Case

Lausanne (SUI), 8 July 2016 – The FEI Tribunal has today published its Final Decision in the case against the Iranian rider Abdulla Mahmood Abdulla Darban (FEI ID 10044343). Samples taken from the horse Lunatica (FEI ID 103JV94/QAT), which finished fourth at the CEI1* in Doha (QAT) on 2 May 2015, returned positive for two prohibited substances, Propranolol and Dexamethasone.

The beta blocker Propranolol, which is used to lower the heart rate, is a banned substance under the FEI’s Equine Anti-Doping and Controlled Medication Rules (EADCMRs). The corticosteroid Dexamethasone is a controlled medication.

The FEI Tribunal has imposed a two-year suspension on the athlete, effective immediately. The period of provisional suspension, which was effective from the date of notification, 23 June 2015, has been credited against the period of ineligibility. This means that the period of ineligibility will now run through to 22 June 2017.

The athlete, who is based in Qatar, is also fined CHF 2,000 and ordered to contribute CHF 1,500 towards the cost of the judicial procedure.

The full Final Decision is available here.

The athlete has 30 days from the date of notification of the Final Decision (7 July 2016) to appeal this decision to the Court of Arbitration for Sport.

The FEI’s Prohibited Substances List is divided into two sections – Controlled Medication and Banned Substances. Controlled Medication substances are those that are regularly used to treat horses, but which must have been cleared from the horse’s system by the time of competition. Banned substances (doping), are substances that should never be found in the body of the horse.

FEI Media Contacts:

Grania Willis
Director Press Relations
+41 787 506 142

Leanne Williams
Manager Press Relations
+41 79 314 24 38

Be Sociable, Share!

Leave a Reply